154 related articles for article (PubMed ID: 8352710)
1. Fatal transfusion-associated graft-vs-host disease.
Otsuka S; Kasuya S; Hirose M
Aust N Z J Med; 1993 Jun; 23(3):308-9. PubMed ID: 8352710
[No Abstract] [Full Text] [Related]
2. Transfusion-associated graft-versus-host disease in an immunocompetent patient.
Capon SM; DePond WD; Tyan DB; Pepkowitz SH; Toyoda H; Cinman AC; Azer PC; Goldfinger D
Ann Intern Med; 1991 Jun; 114(12):1025-6. PubMed ID: 2029098
[No Abstract] [Full Text] [Related]
3. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
Benson K; Marks AR; Marshall MJ; Goldstein JD
Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
[TBL] [Abstract][Full Text] [Related]
4. Graft vs host disease following kidney transplantation using an '0 HLA antigen mismatched' donor.
Smith DM; Agura ED; Levy MF; Melton LB; Domiati-Saad R; Klintmalm G
Nephrol Dial Transplant; 2006 Sep; 21(9):2656-9. PubMed ID: 16627604
[No Abstract] [Full Text] [Related]
5. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
Shivdasani RA; Anderson KC
Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
[TBL] [Abstract][Full Text] [Related]
6. The critical role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease in immunocompetent patients.
Otsuka S; Kunieda K; Kitamura F; Misawa K; Sasaoka I; Hirose M; Kasuya S; Saji S; Noma A
Transfusion; 1991; 31(3):260-4. PubMed ID: 2003327
[TBL] [Abstract][Full Text] [Related]
7. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
[TBL] [Abstract][Full Text] [Related]
8. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
Hovdenes J; Solheim BG
Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
[TBL] [Abstract][Full Text] [Related]
9. HLA-homozygous donors and transfusion-associated graft-versus-host disease.
N Engl J Med; 1990 Apr; 322(14):1004-7. PubMed ID: 2314438
[No Abstract] [Full Text] [Related]
10. Treatment of post-transfusion graft-versus-host disease with nafmostat mesilate, a serine protease inhibitor.
Ryo R; Saigo K; Hashimoto M; Kohsaki M; Yasufuku M; Watanabe N; Okada M; Tadokoro K; Juji T
Vox Sang; 1999; 76(4):241-6. PubMed ID: 10394145
[TBL] [Abstract][Full Text] [Related]
11. Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?
Kanter MH
Transfusion; 1992 May; 32(4):323-7. PubMed ID: 1585436
[TBL] [Abstract][Full Text] [Related]
12. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease.
McMilin KD; Johnson RL
Transfus Med Rev; 1993 Jan; 7(1):37-41. PubMed ID: 8431657
[TBL] [Abstract][Full Text] [Related]
13. HLA-matched blood products and posttransfusion graft-versus-host disease.
Charpentier F; Bracq C; Bonin P; Berling P; Duedari N
Transfusion; 1990; 30(9):850. PubMed ID: 2238036
[No Abstract] [Full Text] [Related]
14. Chronic graft-versus-host disease after blood transfusions confirmed by incompatible HLA antigens in bone marrow.
Siimes MA; Koskimies S
Lancet; 1982 Jan; 1(8262):42-3. PubMed ID: 6119432
[No Abstract] [Full Text] [Related]
15. Transfusion-associated graft-versus-host disease in an immunocompetent patient following accidental injury.
Kobayashi H; Kitano K; Kishi E; Hara K; Ishida F; Saito H; Ota M; Furuta S
Am J Hematol; 1993 May; 43(1):51-3. PubMed ID: 8317463
[TBL] [Abstract][Full Text] [Related]
16. Acute graft-versus-host disease resulting from normal donor blood transfusions.
Burns LJ; Westberg MW; Burns CP; Klassen LW; Goeken NE; Ray TL; Macfarlane DE
Acta Haematol; 1984; 71(4):270-6. PubMed ID: 6426240
[TBL] [Abstract][Full Text] [Related]
17. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
Labotka RJ; Radvany R
Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
[TBL] [Abstract][Full Text] [Related]
18. Transfusion-associated graft-versus-host disease.
Ortiz A; Caramelo C; Plaza JJ; Jiménez Díaz F
N Engl J Med; 1991 Jan; 324(2):128-9. PubMed ID: 1984181
[No Abstract] [Full Text] [Related]
19. [HLA serologically mismatched unrelated bone marrow transplantation].
Kato S
Rinsho Ketsueki; 2006 Jul; 47(7):587-8. PubMed ID: 16910567
[No Abstract] [Full Text] [Related]
20. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.
Spitzer TR; Cahill R; Cottler-Fox M; Treat J; Sacher R; Deeg HJ
Cancer; 1990 Dec; 66(11):2346-9. PubMed ID: 2245390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
